188 related articles for article (PubMed ID: 29142197)
1. Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells.
Imperlini E; Gnecchi M; Rognoni P; Sabidò E; Ciuffreda MC; Palladini G; Espadas G; Mancuso FM; Bozzola M; Malpasso G; Valentini V; Palladini G; Orrù S; Ferraro G; Milani P; Perlini S; Salvatore F; Merlini G; Lavatelli F
Sci Rep; 2017 Nov; 7(1):15661. PubMed ID: 29142197
[TBL] [Abstract][Full Text] [Related]
2. In situ characterization of protein aggregates in human tissues affected by light chain amyloidosis: a FTIR microspectroscopy study.
Ami D; Lavatelli F; Rognoni P; Palladini G; Raimondi S; Giorgetti S; Monti L; Doglia SM; Natalello A; Merlini G
Sci Rep; 2016 Jul; 6():29096. PubMed ID: 27373200
[TBL] [Abstract][Full Text] [Related]
3. Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity.
Martin EB; Williams A; Wooliver C; Heidel RE; Adams S; Dunlap J; Ramirez-Alvarado M; Blancas-Mejia LM; Lands RH; Kennel SJ; Wall JS
PLoS One; 2017; 12(3):e0174152. PubMed ID: 28350808
[TBL] [Abstract][Full Text] [Related]
4. Zebrafish model of amyloid light chain cardiotoxicity: regeneration versus degeneration.
Mishra S; Joshi S; Ward JE; Buys EP; Mishra D; Mishra D; Morgado I; Fisch S; Lavatelli F; Merlini G; Dorbala S; MacRae CA; Liao R
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1158-H1166. PubMed ID: 30875258
[TBL] [Abstract][Full Text] [Related]
5. Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis.
Karimi-Farsijani S; Pfeiffer PB; Banerjee S; Baur J; Kuhn L; Kupfer N; Hegenbart U; Schönland SO; Wiese S; Haupt C; Schmidt M; Fändrich M
Nat Commun; 2024 Jun; 15(1):5121. PubMed ID: 38879609
[TBL] [Abstract][Full Text] [Related]
6. Light chain amyloidosis induced inflammatory changes in cardiomyocytes and adipose-derived mesenchymal stromal cells.
Jordan TL; Maar K; Redhage KR; Misra P; Blancas-Mejia LM; Dick CJ; Wall JS; Williams A; Dietz AB; van Wijnen AJ; Lin Y; Ramirez-Alvarado M
Leukemia; 2020 May; 34(5):1383-1393. PubMed ID: 31796914
[TBL] [Abstract][Full Text] [Related]
7. Role of endocytic inhibitory drugs on internalization of amyloidogenic light chains by cardiac fibroblasts.
Monis GF; Schultz C; Ren R; Eberhard J; Costello C; Connors L; Skinner M; Trinkaus-Randall V
Am J Pathol; 2006 Dec; 169(6):1939-52. PubMed ID: 17148659
[TBL] [Abstract][Full Text] [Related]
8. Truncation of the constant domain drives amyloid formation by immunoglobulin light chains.
Lavatelli F; Natalello A; Marchese L; Ami D; Corazza A; Raimondi S; Mimmi MC; Malinverni S; Mangione PP; Palmer MT; Lampis A; Concardi M; Verona G; Canetti D; Arbustini E; Bellotti V; Giorgetti S
J Biol Chem; 2024 Apr; 300(4):107174. PubMed ID: 38499153
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of Cardiac Amyloidosis.
Morfino P; Aimo A; Franzini M; Vergaro G; Castiglione V; Panichella G; Limongelli G; Emdin M
Heart Fail Clin; 2024 Jul; 20(3):261-270. PubMed ID: 38844297
[TBL] [Abstract][Full Text] [Related]
10. Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma.
Schreiner S; Berghaus N; Poos AM; Raab MS; Besemer B; Fenk R; Goldschmidt H; Mai EK; Müller-Tidow C; Weinhold N; Hegenbart U; Huhn S; Schönland SO
Amyloid; 2024 Jun; 31(2):86-94. PubMed ID: 38206120
[TBL] [Abstract][Full Text] [Related]
11. Oxidative Post-Translational Modifications of an Amyloidogenic Immunoglobulin Light Chain Protein.
Lu Y; Jiang Y; Prokaeva T; Connors LH; Costello CE
Int J Mass Spectrom; 2017 May; 416():71-79. PubMed ID: 29358899
[TBL] [Abstract][Full Text] [Related]
12. New concepts in the treatment and diagnosis of amyloidosis.
Milani P; Palladini G; Merlini G
Expert Rev Hematol; 2018 Feb; 11(2):117-127. PubMed ID: 29307226
[TBL] [Abstract][Full Text] [Related]
13. CKD stage V in AL amyloidosis: is it too late to treat? Maybe not.
Leung N
Kidney Int; 2017 Dec; 92(6):1321-1322. PubMed ID: 29153137
[TBL] [Abstract][Full Text] [Related]
14. Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort study.
Campbell JP; Heaney JLJ; Pandya S; Afzal Z; Kaiser M; Owen R; Child JA; Cairns DA; Gregory W; Morgan GJ; Jackson GH; Bunce CM; Drayson MT
Lancet Haematol; 2017 Dec; 4(12):e584-e594. PubMed ID: 29146225
[TBL] [Abstract][Full Text] [Related]
15. AL amyloidosis: from molecular mechanisms to targeted therapies.
Merlini G
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):1-12. PubMed ID: 29222231
[TBL] [Abstract][Full Text] [Related]
16. Concurrent structural and biophysical traits link with immunoglobulin light chains amyloid propensity.
Oberti L; Rognoni P; Barbiroli A; Lavatelli F; Russo R; Maritan M; Palladini G; Bolognesi M; Merlini G; Ricagno S
Sci Rep; 2017 Dec; 7(1):16809. PubMed ID: 29196671
[TBL] [Abstract][Full Text] [Related]
17. Adverse Prognostic Factors for Morbidity and Mortality During Peripheral Blood Stem Cell Mobilization in Patients with Light Chain Amyloidosis.
Yeh JC; Shank BR; Milton DR; Qazilbash MH
Biol Blood Marrow Transplant; 2018 Apr; 24(4):815-819. PubMed ID: 29223373
[TBL] [Abstract][Full Text] [Related]
18. A case report of proliferative glomerulonephritis with monoclonal immunoglobulin M-kappa deposits without associated lymphoproliferative disorder or detectable paraproteinemia.
Yamaguchi Y; Maeda K; Nagatoya K; Yamauchi A
CEN Case Rep; 2018 May; 7(1):55-61. PubMed ID: 29230710
[TBL] [Abstract][Full Text] [Related]
19. Case Report: Treatment of light-chain amyloidosis with daratumumab monotherapy in two patients.
Gran C; Gahrton G; Alici E; Nahi H
Eur J Haematol; 2018 Apr; 100(4):386-388. PubMed ID: 29226427
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics and prognostic analysis of monoclonal IgM-related AL amyloidosis].
Mao YY; Feng J; Meng Q; Shen KN; Cao XX; Zhou DB; Li J
Zhonghua Xue Ye Xue Za Zhi; 2017 Nov; 38(11):989-992. PubMed ID: 29224328
[No Abstract] [Full Text] [Related]
[Next] [New Search]
